WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healin... ( Studies at UT Southwestern to Leverag...)

HOME >> BIOLOGY >> TECHNOLOGY

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research

Date:3/24/2009

Studies at UT Southwestern to Leverage WaferGen's SmartChip Platform to Evaluate Efficacy of ImmuneRegen's Drug

FREMONT, Calif. and SCOTTSDALE, Ariz., March 24 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, and IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBS), a development-stage biotechnology company focused on the research, development and licensing of ImmuneRegen's wound healing drug candidate, Homspera(R), today announced the establishment of a novel wound healing research collaboration with the University of Texas Southwestern Medical Center. Under terms of the collaboration, UT Southwestern researchers will conduct preclinical and clinical studies to evaluate the efficacy of Homspera. As part of these studies, WaferGen's SmartChip(TM) Real-Time PCR System will be used to understand the mechanism of action of Homspera.

The collaborators believe that these studies may demonstrate the key role that the innovative capabilities of the SmartChip system can play in the field of drug development, particularly in validating relevant gene expression biomarkers and assessing their impact on patient response to treatment. Additionally, the studies are expected to provide ImmuneRegen with important data to support potential applications for Homspera in a range of therapeutic applications.

These studies, which provide the first opportunity for the SmartChip platform to assist in the drug development process, are expected to demonstrate the following key SmartChip system capabilities:

Support of both preclinical and clinical studies
Validating potential biomarkers in many samples with rapid turnaround time, allowing for expedited drug development decisions
High sensitivity and accuracy with limited amount of sample from needle
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
2. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
3. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
4. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
5. WaferGen Announces Third Quarter 2008 Financial Results
6. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
7. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
8. WaferGen to Present at the Seventh Annual BIO Investor Forum
9. WaferGen Announces Second Quarter 2008 Financial Results
10. WaferGen to Present at the Ninth Annual Beyond Genome Conference
11. WaferGen Announces Signing of Two Private Placements

Post Your Comments:

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healin...( Studies at UT Southwestern to Leverag...)